Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Danova

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Tumori|July 27, 2011
Single-dose palonosetron and dexamethasone in preventing nausea and vomiting induced by moderately emetogenic chemotherapy in breast and colorectal cancer patientsSilvia Brugnatelli, Elisabetta Gattoni, Donatella Grasso, et al.
Expert Review of Anticancer Therapy|September 16, 2011
Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumorsMarco Danova, Sandro Barni, Lucia Del Mastro, et al.
Anticancer Research|November 1, 2007
In vivo biological effects of pegfilgrastim after myelosuppressive chemotherapy in breast cancerMarco Danova, Katia Bencardino, Mariangela Manzoni, et al.
Recenti Progressi in Medicina|November 5, 2009
[Role of loco-regional treatments for patients with breast cancer liver metastases]Cristina Raimondi, Marco Danova, Sofia Chatzileontiadou, et al.
Lung Cancer (Amsterdam, Netherlands)|October 26, 2002
Intrapleural interleukin-2 induces nitric oxide production in pleural effusions from malignant mesothelioma: a possible mechanism of interleukin-2-mediated cytotoxicity?Camillo Porta, Vittoria Rizzo, Matteo Zimatore, et al.
Biomedical Reports|March 24, 2015
Diabetes and cancer: A critical appraisal of the pathogenetic and therapeutic linksValerio Gristina, Maria Grazia Cupri, Martina Torchio, et al.
Geriatrics (Basel, Switzerland)|April 30, 2021
Anti-Cancer Treatment Strategies in the Older Population: Time to Test More?Antonino C Tralongo, Roberto S Fratamico, Chiara Russo, et al.
Tumori|June 16, 2020
Management of chemotherapy-induced neutropenia in patients with cancer: 2019 guidelines of the Italian Medical Oncology Association (AIOM)Antonino C Tralongo, Andrea Antonuzzo, Paolo Pronzato, et al.
Cancer|May 13, 2004
Gemcitabine and oxaliplatin in the treatment of patients with immunotherapy-resistant advanced renal cell carcinoma: final results of a single-institution Phase II studyCamillo Porta, Matteo Zimatore, Ilaria Imarisio, et al.
Oncology Letters|August 15, 2014
Late-onset sarcoidosis in a patient with gastric mucosa-associated lymphoid tissue non-Hodgkin lymphoma: A case reportMartina Torchio, Giorgio Bottaro, Giampiera Bertolino, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Tumori|July 27, 2011
Single-dose palonosetron and dexamethasone in preventing nausea and vomiting induced by moderately emetogenic chemotherapy in breast and colorectal cancer patientsSilvia Brugnatelli, Elisabetta Gattoni, Donatella Grasso, et al.
Expert Review of Anticancer Therapy|September 16, 2011
Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumorsMarco Danova, Sandro Barni, Lucia Del Mastro, et al.
Anticancer Research|November 1, 2007
In vivo biological effects of pegfilgrastim after myelosuppressive chemotherapy in breast cancerMarco Danova, Katia Bencardino, Mariangela Manzoni, et al.
Recenti Progressi in Medicina|November 5, 2009
[Role of loco-regional treatments for patients with breast cancer liver metastases]Cristina Raimondi, Marco Danova, Sofia Chatzileontiadou, et al.
Lung Cancer (Amsterdam, Netherlands)|October 26, 2002
Intrapleural interleukin-2 induces nitric oxide production in pleural effusions from malignant mesothelioma: a possible mechanism of interleukin-2-mediated cytotoxicity?Camillo Porta, Vittoria Rizzo, Matteo Zimatore, et al.
Biomedical Reports|March 24, 2015
Diabetes and cancer: A critical appraisal of the pathogenetic and therapeutic linksValerio Gristina, Maria Grazia Cupri, Martina Torchio, et al.
Geriatrics (Basel, Switzerland)|April 30, 2021
Anti-Cancer Treatment Strategies in the Older Population: Time to Test More?Antonino C Tralongo, Roberto S Fratamico, Chiara Russo, et al.
Tumori|June 16, 2020
Management of chemotherapy-induced neutropenia in patients with cancer: 2019 guidelines of the Italian Medical Oncology Association (AIOM)Antonino C Tralongo, Andrea Antonuzzo, Paolo Pronzato, et al.
Cancer|May 13, 2004
Gemcitabine and oxaliplatin in the treatment of patients with immunotherapy-resistant advanced renal cell carcinoma: final results of a single-institution Phase II studyCamillo Porta, Matteo Zimatore, Ilaria Imarisio, et al.
Oncology Letters|August 15, 2014
Late-onset sarcoidosis in a patient with gastric mucosa-associated lymphoid tissue non-Hodgkin lymphoma: A case reportMartina Torchio, Giorgio Bottaro, Giampiera Bertolino, et al.
Pageof 8